In an IVF cycle, how long should subcutaneous estradiol, vaginal or subcutaneous progesterone, and low‑dose aspirin be continued?

Duration of Hormonal Support and Aspirin in IVF Cycles

In IVF cycles, continue estradiol and progesterone for 3-4 weeks after pregnancy confirmation, then taper over 2 weeks before discontinuation; aspirin should be stopped at pregnancy confirmation or avoided entirely as it provides no proven benefit.

Estradiol and Progesterone Duration

Standard Protocol for HRT-FET Cycles

• Continue both estradiol and progesterone at original doses for 3-4 weeks after pregnancy confirmation, then gradually reduce dosage over 2 weeks before complete discontinuation 1
• For HRT-FET cycles specifically, estradiol valerate 6 mg daily and vaginal progesterone 400 mg twice daily should be maintained through early pregnancy 1
• This recommendation comes from the American Society for Reproductive Medicine and Human Reproduction Update guidelines, representing the current standard of care 1

Natural or Stimulated Cycles

• In natural or stimulated cycles, luteal support should continue for 1-3 weeks after ultrasound confirmation of viable intrauterine pregnancy 1
• This shorter duration reflects the presence of endogenous corpus luteum function in these cycles 1

Evidence Supporting Early Discontinuation

• High-quality research demonstrates that progesterone supplementation can be safely withdrawn at the time of a positive HCG test without affecting delivery rates 2
• A randomized controlled trial of 303 women showed no significant difference in miscarriage rates (4.6% vs 3.3% early, 10.0% vs 8.5% late) or delivery rates (78.7% vs 82.4%) between stopping progesterone at positive HCG versus continuing for 3 additional weeks 2
• However, current guidelines recommend the more conservative 3-4 week continuation approach 1

Route-Specific Considerations

• Vaginal progesterone 400 mg twice daily is the standard route for HRT-FET cycles 1
• Subcutaneous progesterone follows similar timing principles, though vaginal administration remains more commonly recommended in guidelines 1
• Most patients will begin bleeding despite continued progesterone if not pregnant, with mean onset at 16.2 days after oocyte retrieval 3

Aspirin Recommendations

Evidence Against Routine Use

• Low-dose aspirin should NOT be routinely prescribed in IVF/ICSI treatment as multiple randomized controlled trials show no benefit 4
• A double-blind RCT of 201 couples found identical clinical pregnancy rates between aspirin 100 mg and placebo (32% vs 31%, P=0.916) 4
• Another RCT of 145 women showed aspirin did not improve implantation or pregnancy rates 5

Potential Harm with Higher Doses

• High-dose aspirin (162 mg) may negatively impact pregnancy outcomes, with trends toward lower clinical pregnancy rates and significantly increased miscarriage risk 6
• A 2025 study of 1207 FET cycles found higher hematoma formation rates with 162 mg versus 81 mg aspirin 6
• Multiple regression analysis showed higher aspirin dosage significantly increased miscarriage rates 6

If Aspirin is Used

• If aspirin is prescribed for specific indications (not routine IVF), use 81 mg daily rather than higher doses 6
• Discontinue at pregnancy confirmation or when fetal heart activity is detected on ultrasound 4
• Starting aspirin before stimulation and continuing through early pregnancy showed no benefit in unselected IVF populations 4, 5

Clinical Algorithm

For HRT-FET Cycles:

1. Continue estradiol 6 mg daily + progesterone 400 mg twice daily (vaginal) through positive pregnancy test 1
2. Maintain same doses for 3-4 weeks after pregnancy confirmation 1
3. Gradually taper both medications over 2 weeks 1
4. Complete discontinuation by approximately 7-9 weeks gestational age 1

For Natural/Stimulated Cycles:

1. Continue luteal support through positive pregnancy test 1
2. Maintain for 1-3 weeks after ultrasound confirms viable intrauterine pregnancy 1
3. Discontinue once fetal viability established 1

For Aspirin:

1. Do not routinely prescribe for IVF cycles 4
2. If used for other medical indications, limit to 81 mg daily 6
3. Stop at pregnancy confirmation 4

Important Caveats

• The more conservative guideline approach (3-4 weeks post-confirmation) is recommended despite research showing safety of earlier discontinuation, as this provides an additional margin of safety 1, 2
• Anovulatory women and those with inadequate corpus luteum function may require the full duration of support 1
• Progesterone levels remain supraphysiologic with supplementation, which may prolong the luteal phase in some patients 3
• Avoid abrupt discontinuation—always taper hormonal support to prevent sudden withdrawal 1